Neimeth, Prisons Service join fight against hypertension
TO join in the fight against hypertension among Nigerians, Neimeth recently collaborated with the Nigerian Prisons Service through its innovative healthcare with the launch of a programme tagged FITGAH (Fight the Good Fight Against Hypertension).
During the launch, the healthcare professionals declared hypertension as a national health emergency and challenged well-meaning Nigerians to contribute to the fight against hypertension in the society.
According to the Head, Corporate Affairs of Neimeth, who was represented by Mr. Okey Nwaka, “hypertension, like other non-communicable diseases, has a high prevalence and is worsening in our nation. It is assuming an epidemic status leading to sudden death, stroke, among others.”
“Neimeth, as good corporate citizen, and in pursuance of her strategic Corporate Social Responsibility (CSR) programme, took deliberate steps to significantly contribute to the reduction in death occasioned by hypertension- endemic healthcare issues that do not necessarily present as sickness at the initial stage.”
“FITGAH is a direct intervention programme, which applies four-ALPHA pronged approach namely: Awareness, Availability, Affordability and Action.
These informed the management’s decision to reduce the cost of Neimeth’s Anti-hypertensives such as Amlovar, Miniplus, Normoreti and Norduet by 50 per cent. The reduction in prices will certainly erode profit but Neimeth is committed to complementing effort of the government through FITGAH-an endearing legacy of caring.
FITGAH – adopts a multiphasic approach, namely: mass screening and free provision of starter drugs; initiate Mass Media and Educational Programme for targeted communities or geo-political groups; coalition with Nigeria Heart Foundation, Hypertension Society of Nigeria, among others for direct professional implementation of FITGAH and voluntary lowering of prices of Neimeth of anti-hypertensives.
This means more affordability, of these essential drugs to Nigerians who may not be able to afford it.
No comments yet